Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: Promising long-term results of the Radiation Therapy Oncology Group-RTOG 9705

Journal of Clinical Oncology

Volumn 23, Issue 15, 2005, Pages 3480-3487

  Bradley, Jeffrey D ^a   Paulus, Rebecca ^a   Graham, Mary V ^a   Ettinger, David S ^a   Johnstone, David W ^a   Pilepich, Miljenko V ^a   Machtay, Mitchell ^a   Komaki, Ritsuko ^a   Atkins, James ^a   Curran, Walter J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PACLITAXEL; ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; AGED; ALLERGY; ANEMIA; ARTICLE; BLEEDING; BRAIN METASTASIS; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG DOSE INCREASE; ESOPHAGUS DISEASE; FEMALE; FEVER; FOLLOW UP; GRANULOCYTOPENIA; HEART DISEASE; HUMAN; INFECTION; KIDNEY DISEASE; LEUKOPENIA; LIVER TOXICITY; LUNG DISEASE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUROLOGIC DISEASE; PAIN; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIATION DOSE; SEPSIS; SKIN DISEASE; STOMATITIS; THROMBOCYTOPENIA; TREATMENT OUTCOME; UROGENITAL TRACT DISEASE; ADJUVANT CHEMOTHERAPY; COMPARATIVE STUDY; DOSE RESPONSE; LUNG RESECTION; LUNG TUMOR; MAXIMUM TOLERATED DOSE; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; POSTOPERATIVE CARE; RISK ASSESSMENT; SURVIVAL;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; PNEUMONECTOMY; POSTOPERATIVE CARE; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 20644457720     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.12.120     Document Type: Article

References (21)

1. Mountain CF: A new international staging system for lung cancer. Chest 89:2255-2335, 1986
2. Mountain CF: Value of the new TNM staging system for lung cancer. Chest 96:475-495, 1989 (suppl 1)
3. Mountain C: Prognostic implications of the international staging system for lung cancer. Semin Oncol 15:236-245, 1988
4. Israel L, Bonadonna G, Sylvester R, et al: Controlled study with adjuvant radiotherapy, chemotherapy, immunotherapy, and chemoimmunotherapy in operable squamous carcinoma of the lung, in Rozencweig M, Muggia F (eds): Lung Cancer: Progress in Therapeutic Research. New York, NY, Raven Press, 1979, pp 443-452
5. Stephens RJ, Girling DJ, Bleehen NM, et al: The role of postoperative radiotherapy in non-small cell lung cancer: A multicentre randomized trial in patients with pathologic T1-2, N1-2, MO disease. Br J Cancer 74:632-639, 1996
6. Lung Cancer Study Group: Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. N Engl J Med 315:1377-1381, 1986
7. Sawyer TE, Bonner JA, Gould PM, et al: The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvement. Cancer 80:1399-1408, 1997
8. Keller SM, Adak S, Wagner H, et al: A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer: Eastern Cooperative Oncology Group. N Engl J Med 343:1217-1222, 2000
9. van Houtte P, Rocmans P, Smets P, et al: Postoperative radiotherapy in lung cancer: A controlled trial after resection of curative design. Int J Radiat Oncol Biol Phys 6:983-986, 1980
10. Lafitte JJ, Ribet ME, Prevost BM, et al: Postresection irradiation for T2 NO MO non-small cell carcinoma: A prospective, randomized study. Ann Thorac Surg 62:830-834, 1996
11. Dautzenberg B, Arriagada R, Chammard AB, et al: A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Cancer 86:265-273, 1999
12. Bangma PJ: Postoperative radiotherapy, in Deeley TJ (ed): Carcinoma of the Bronchus: Modern Radiotherapy. New York, NY, Appleton-Century-Crofts, 1972, pp 163-170
13. Patterson R, Russell MH: Clinical trials in malignant disease. IV: Lung Cancer-Value of postoperative radiotherapy. Clin Radiol 13:141-144, 1961
14. PORT Meta-analysis Trialists Group: Postoperative radiotherapy in nonsmall cell lung cancer: Systematic review and meta-analysis of individual patient data from nine randomised clinical trials. Lancet 352:257-263, 1998
15. Lung Cancer Study Group: The benefits of adjuvant treatment for resected locally advanced non-small cell lung cancer. J Clin Oncol 6:9-17, 1988
16. Dautzenberg B, Chanstang C, Arriagada R: Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected non-small cell lung carcinoma: A randomized trial of 267 patients. Cancer 76:779-786, 1995
17. Non-Small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 311:899-909, 1995
18. Bonomi P, Kim K, Fairclough D: Comparison of survival and quality of life in advanced non-small cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: Results of an Eastern Cooperative Oncology Group trial. J Clin Oncol 18:623-631, 2000
19. Schiller JH, Harrington D, Belani CP, et al: Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346:92-98, 2002
20. LeChevalier T, for the IALT Investigators: Results of the randomized International Lung CAncer Trial (IALT): Cisplatin-based chemotherapy (CT) vs no CT in 1867 patients (pts) with resected non-small cell lung cancer (NSCLC), Alexandria, VA, American Society of Clinical Oncology, 2003, pp 32
21. Le Pechoux C, Pignon J, Quiox E, et al: Impact of Adjuvant Chemotherpay (CT) on survival and local-control in non-small cell lung cancer (NSCLC): Results of the International Adjuvant Lung Cancer Trial (IALT). Int J Radiat Oncol Biol Phys 60:177A, 2004 (suppl 1)